1. An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers
   Reiko Fukui et al, 2023, Breast Cancer CrossRef
2. Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
   Jesús Fuentes-Antrás et al, 2020, Frontiers in Oncology CrossRef
3. The Immunology of Hormone Receptor Positive Breast Cancer
   Jonathan Goldberg et al, 2021, Frontiers in Immunology CrossRef
4. Pengaruh Ekstrak Daun Sirsak terhadap Ekspresi CD8 pada Populasi Limfosit Tumor Payudara Tikus Sparaque Dawley
   Soilia Fertilita et al, 2020, Jurnal Manajemen Kesehatan Yayasan RS.Dr. Soetomo CrossRef
5. Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
   Rashmi Verma et al, 2020, Breast Cancer Research and Treatment CrossRef
6. Foods may modify responsiveness to cancer immune checkpoint blockers by altering both the gut microbiota and activation of estrogen receptors in immune cells
   Leena Hilakivi-Clarke et al, 2022, Frontiers in Microbiomes CrossRef
7. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival
   Maiko Okano et al, 2019, International Journal of Molecular Sciences CrossRef
8. Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer
   Giuseppe Angelico et al, 2021, Applied Sciences CrossRef